Fate of indium 111-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators.
To elucidate the effects of bubble and membrane oxygenators on platelet integrity, we developed a quantitative method of determining platelet lysis during cardiopulmonary bypass. Two groups of dogs whose platelets had been labeled with indium 111 were subjected to 1 hour of cardiopulmonary bypass. In Group A (bubble oxygenator), platelet lysis as measured by free plasma 111In levels increased from 6% +/- 1% to 33% +/- 7% during bypass. In Group B (membrane oxygenator), plasma 111In levels increased from 5% +/- 2% to 10% +/- 6% during bypass (p less than 0.01). After 1 hour of bypass, the ratio of 111In-labeled platelets to prebypass levels was 36% +/- 8% in Group A and 67% +/- 9% in Group B. Platelet deposition on the oxygenator was greater in bubble oxygenators (19% +/- 4% of total injected 111In) than in membrane oxygenators (12% +/- 3% of total injected 111In). These data indicated that membrane oxygenators maintain a higher circulating platelet count both intraoperatively and postoperatively and result in less platelet destruction than bubble oxygenators following 1 hour of cardiopulmonary bypass in dogs.
D000818:Animals; D001792:Blood Platelets; D002315:Cardiopulmonary Bypass; D004285:Dogs; D006438:Hemodilution; D007204:Indium; D010106:Oxygenators / Q000592:standards*; D010107:Oxygenators, Membrane / Q000592:standards; D010953:Plasma Volume; D010976:Platelet Count; D011868:Radioisotopes
D011868:Radioisotopes; D007204:Indium